ScholarIQanswers from OpenAlex
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
PaperCitations, authors & open-access status
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Idarucizumab for Dabigatran Reversal — Full Cohort Analysis have?
ScholarIQcitation count
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis has 1,144 citations in the OpenAlex counts ScholarIQ stores.
When was Idarucizumab for Dabigatran Reversal — Full Cohort Analysis published?
ScholarIQyear
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis has 2017 year in the ScholarIQ index.
What is the open-access status of Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
ScholarIQoa status
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis has bronze oa status in the ScholarIQ index.
What is the DOI of Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
ScholarIQdoi
The DOI for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is on the source record.
What is the PMID of Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
ScholarIQpmid
The PMID for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is on the source record.
What is the OpenAlex record for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
ScholarIQopenalex
The OpenAlex for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is on the source record.